VR Logo

Unrated

UTI Healthcare Fund - Regular Plan


1 Lakh

Investment Grown to
₹ 1.58 Lakh

₹ 10000

Monthly SIP Grown to
₹ 5.23 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 51.99 2.14 1.38 3.17 21.52 68.76 63.02 16.55 5.33 13.25 13.14
S&P BSE Healthcare TRI 48.70 2.22 1.14 2.91 20.62 71.05 56.99 14.71 3.04 11.79 13.45
Equity: Sectoral-Pharma 51.01 1.86 0.71 3.00 20.97 65.27 61.03 17.42 5.57 15.01 14.70
Rank within category 4 4 1 4 3 4 4 3 2 3 3
Number of funds in category 9 9 9 9 9 9 9 4 3 3 3

As on 28-Sep-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
UTI Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jun-99 63.02 16.55 5.33 2.81 563
Nippon India Pharma Fund
Unrated
Jun-04 58.67 20.89 7.96 2.09 3,653
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 67.49 -- -- 2.47 1,849
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 60.31 13.51 3.43 2.23 1,361
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 69.31 -- -- 2.42 876

Best & Worst Performance

Best (Period) Worst (Period)
Week 21.24 (01-Apr-2020 - 09-Apr-2020) -16.12 (15-Jan-2008 - 22-Jan-2008)
Month 34.24 (23-Mar-2020 - 22-Apr-2020) -31.35 (09-May-2006 - 08-Jun-2006)
Quarter 44.96 (23-Mar-2020 - 22-Jun-2020) -27.70 (02-Sep-2008 - 03-Dec-2008)
Year 99.77 (25-Mar-2009 - 25-Mar-2010) -26.83 (31-Dec-2007 - 30-Dec-2008)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 15.42 21.30 0.48 1.01 0.89 1.99
S&P BSE Healthcare TRI 14.48 23.46 0.40 0.94 -- --
Equity: Sectoral-Pharma 16.32 20.67 0.54 1.12 0.86 3.20
Rank within category 3 3 3 3 4 3
Number of funds in category 4 4 4 4 4 4

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Aug-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 24
Top 10 Stocks (%) 65.63
Top 5 Stocks (%) 44.62
Top 3 Sectors (%) 97.18
Portfolio P/B Ratio 4.66
Portfolio P/E Ratio 35.58

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 34,710 32,978
Giant (%) 12.26 11.02
Large (%) 46.29 46.32
Mid (%) 30.85 30.77
Small (%) 10.61 11.89
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Sun Pharmaceutical Inds. Healthcare 169.58 15.05 5.73 11.91
down Dr. Reddy's Lab Healthcare 43.85 11.67 0.00 10.05
up Divi's Laboratories Healthcare 51.44 9.85 1.12 9.85
equal Cipla Healthcare 37.94 10.43 3.52 6.49
up Ipca Laboratories Healthcare 28.55 7.79 2.06 6.32
equal Aurobindo Pharma Healthcare 15.78 8.62 2.36 4.75
down Laurus Labs Healthcare 37.99 4.98 0.00 4.63
up Cadila Healthcare Healthcare 30.13 9.87 1.26 4.00
up Eris Lifesciences Healthcare 24.18 4.47 0.00 3.98
down Biocon Healthcare 78.18 6.05 0.00 3.65
down Ajanta Pharma Healthcare 27.65 5.75 2.36 3.46
equal Narayana Hrudayalaya Healthcare -- 3.49 0.00 3.34
up Torrent Pharmaceuticals Healthcare 40.32 8.05 2.00 3.29
up Pfizer Healthcare 44.04 7.52 0.00 3.16
down Lupin Healthcare -- 9.90 0.00 2.90
up Abbott India Healthcare 52.84 2.67 0.00 2.67
up Sanofi India Healthcare 43.91 6.60 1.84 2.46
down Apollo Hospitals Healthcare 151.21 3.05 0.00 1.77
up Advanced Enzyme Technologies FMCG 25.89 1.72 0.00 1.72
up Dr. Lal Pathlabs Healthcare 81.01 2.94 1.39 1.67
up Metropolis Healthcare Healthcare 91.07 1.64 0.00 1.64
up Alembic Pharmaceuticals Healthcare 19.82 1.59 0.00 1.59
equal FDC Healthcare 22.71 4.36 1.27 1.27
equal Alkem Laboratories Healthcare 24.30 8.56 0.60 0.61

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Aug-2020

Fund Manager

— V Srivatsa since 02-Mar-2017

Education: Mr. Srivatsa is a B.Com (H), Chartered Accountant, CWA. and PGDM from IIM Indore.

Experience: Prior to joining UTI in 2002 he has worked with Ford, Rhodes Parks & Co., Chartered Accountants and Madras Cements Ltd.

Funds Managed:


2.14%

Change from previous, NAV as on 28-Sep-2020

Growth: ₹ 129.1632

Dividend: ₹ 99.8248


Investment Strategy

The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 6
Minimum Withdrawal (₹) --
Minimum Balance (₹) 5,000
Exit Load 1% for redemption within 364 days

Basic Details

Fund House: UTI Mutual Fund
Launch Date: 28-Jun-1999
Return Since Launch: 14.26%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 563 Cr (As on 31-Aug-2020)
Expense: 2.81% (As on 31-Aug-2020)
Risk Grade: --
Return Grade: --
Turnover: 64.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
Dividend28-Oct-20101.7000

 26-Aug-20081.5000
 10-Jan-20062.5000
 10-Nov-20042.5000
 21-Nov-20032.0000

Contact Information

AMC: UTI Asset Management Company Ltd

Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051

Phone: 022- 66786666 / 66786354 / 1800-22-1230

Fax: 022-26523031

Email: [email protected]

Website: http://www.utimf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Delving into exchange-traded funds (ETFs)

dateFriday, 09-Oct-2020
time12:30 PM - 01:00 PM